Structure-directed identification of pyridine-2-methylamine derivatives as MmpL3 inhibitors for use as antitubercular agents.

ABSTRACT: Mycobacterial membrane protein Large 3 (MmpL3), an inner membrane protein, plays a crucial role in the transport of mycolic acids that are essential for the viability of M. tuberculosis and has been a promising therapeutic target for new anti-TB agents. Herein, we report the discovery of pyridine-2-methylamine antitubercular compounds using a structure-based drug design strategy. Compound 62 stands out as the most potent compound with high activity against M. tb strain H37Rv (MIC = 0.016 μg/mL) as well as the clinically isolated strains of MDR/XDR-TB (MIC = 0.0039-0.0625 μg/mL), low Vero cell toxicity (IC₅₀ ≥ 16 μg/mL), and moderate liver microsomal stability (CL_int = 28 μL/min/mg). Furthermore, the resistant mutant of S288T due to single nucleotide polymorphism in mm

SUBMITTER: Wen Y 

PROVIDER: S-EPMC10239758 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature